TITLE

Randomized Control Trial of Continuous Glucose Monitoring Devices on HbA1c--The MITRE Study

AUTHOR(S)
Newman, Stanton P.; Hurel, Steven J.; Cooke, Debbie; Steed, Elizabeth; Nunn, Andrew; Meredith, Sarah; Casbard, Angela
PUB. DATE
June 2007
SOURCE
Diabetes;Jun2007 Supplement 1, Vol. 56, pA30
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a randomized controlled trial of continuous glucose monitoring system (CGMS) on glycosylated hemoglobin. It mentions that this study aims to evaluate the efficacy of minimally invasive glucose monitoring devices in diabetics treated with insulin. It states that patients were randomly assigned to the CGMS, Biographer, standard control and an attention control group.
ACCESSION #
25820434

 

Related Articles

  • Progressive resistance exercise improves glycaemic control in people with type 2 diabetes mellitus: a systematic review. Irvine, Casey; Taylor, Nicholas F. // Australian Journal of Physiotherapy;2009, Vol. 55 Issue 4, p237 

    Question: Is progressive resistance exercise a safe and effective form of exercise to improve glycaemic control in people with type 2 diabetes? Design: Systematic review with meta-analysis of randomised controlled trials. Participants: People with type 2 diabetes mellitus. Intervention:...

  • Evaluating the Optimal Frequency of Self-Monitoring Blood Glucose in Type 2 Diabetes at Glycaemic Target -A Multi-centre, Randomized Controlled Trial. Scherbaum, Werner A.; Ohmann, Christian; Abholz, Heinz H.; Lankisch, Mark // Diabetes;Jun2007 Supplement 1, Vol. 56, pA24 

    Background: Self-monitoring of blood glucose (SMBG) is an integral part of disease management in type 2 diabetes(T2D). Recommendations on the frequency of SMBG vary widely among physicians treating T2D patients. A recent consensus conference in the USA recommended 11 times SMBG per week in T2D...

  • Evaluation of Self Monitoring of Blood Glucose in Non-Insulin-Treated Diabetic Patients by Randomized Controlled Trials: Little Bang for the Buck. Davidson, Mayer B. // Reviews on Recent Clinical Trials;Sep2010, Vol. 5 Issue 3, p138 

    Although self monitoring of blood glucose is accepted to be effective in lowering Hb A1c levels in insulin- treated diabetic patients, any benefit in non-insulin-treated patients remains controversial. Observational studies cannot answer this question because of either patient self selection...

  • Multiple Daily SMBG Is Strongly Associated with Optimal Glucose Control in CSII Patients. Heinemann, Lutz; Renard, Eric; Grunder, Stefan; Buhr, Andreas; Schweitzer, Matthias A. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA23 

    SMBG is a mandatory component of successful intensive diabetes management, specifically in insulin treated diabetic patients. However, limited data exist from clinical trials about the relationship between SMBG frequency and HbA1c outcome in CSII patients. In this international survey, questions...

  • Real Life Data on the Switch from Nph to Glargine in Type 1 Diabetics. McEwan, Phil; Sharplin, Peter; Mehin, Nazanin; Tetlow, Tony // Diabetes;Jun2007 Supplement 1, Vol. 56, pA658 

    This study is a real life evaluation of glycemic control in Type 1 diabetes' patients who are introduced to insulin glargine therapy after switching from NPH therapy. Based on data from the THIN database (The Health Improvement Network), a UK GP database including 2,335,667 patients followed...

  • 2012 - Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%. Willett, Laura Rees // ACP Journal Club;6/19/2012, Vol. 156 Issue 6, p1 

    The article focuses on a study on the self monitoring of blood glucose to improve glycemic control in patients with type 2 diabetes. It informs that self monitoring of blood glucose was compared with no self-monitoring in patients with non-insulin-treated type 2 diabetes and the primary outcome...

  • Effectiveness of Switch from NPH to Glargine in Type 2 Diabetics. Sharplin, Peter; Mehin, Nazanin; McEwan, Phil; Tetlow, Tony // Diabetes;Jun2007 Supplement 1, Vol. 56, pA657 

    This study is a real life evaluation of glycemic control in Type 2 diabetes' patients who are introduced to insulin glargine therapy after switching from NPH therapy. Based on data from the THIN database (The Health Improvement Network), a UK GP database including 2,335,667 patients followed...

  • Continuous Glucose Monitoring Systems: A Review. Vashist, Sandeep Kumar // Diagnostics (2075-4418);Dec2013, Vol. 3 Issue 4, p385 

    There have been continuous advances in the field of glucose monitoring during the last four decades, which have led to the development of highly evolved blood glucose meters, non-invasive glucose monitoring (NGM) devices and continuous glucose monitoring systems (CGMS). Glucose monitoring is an...

  • Review: Continuous glucose monitoring reduces HbAIc more than self-monitoring in type 1 diabetes. Felix Burden, A. C. // Annals of Internal Medicine;3/19/2013, Vol. 158 Issue 6, pJC9 

    The article offers information on comparison of methods of insulin delivery and glucose monitoring for glycemic control in patients with type 1 or type 2 diabetes mellitus. It informs that several methods including MEDLINE and Excerpta Medica INC. were used for observing for randomized...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics